Metabolomics of human intestinal transplant rejection

American Journal of Transplantation

Volumn 12, Issue SUPPL 4, 2012, Pages

  Girlanda, R ^a   Cheema, A K ^b   Kaur, P ^b   Kwon, Y ^a   Li, A ^a   Guerra, J ^a   Matsumoto, C S ^a   Zasloff, M ^a   Fishbein, T M ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Acute allograft rejection; Biomarkers; Immunosuppression; Noninvasive monitoring

Indexed keywords

LEUKOTRIENE E4; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; TAUROCHOLIC ACID; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; CHILD; CHROMATOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MARKER; FEASIBILITY STUDY; FEMALE; GRAFT REJECTION; HUMAN; ILEOSTOMY; INFANT; INTESTINE FLORA; INTESTINE GRAFT REJECTION; INTESTINE TRANSPLANTATION; IONIZATION; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ALLOTRANSPLANTATION; ARTICLE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; ORGAN TRANSPLANTATION; PILOT STUDY; SMALL INTESTINE; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; FEMALE; GRAFT REJECTION; HUMANS; ILEOSTOMY; INFANT; INTESTINE, SMALL; LEUKOTRIENE E4; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; ORGAN TRANSPLANTATION; PILOT PROJECTS; RIBOFLAVIN; TAUROCHOLIC ACID; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84879520861     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04183.x     Document Type: Conference Paper

References (37)

1. Fishbein TM. Intestinal transplantation. N Engl J Med 2009;361:998-1008.
2. Blow N. Metabolomics: Biochemistry's new look. Nature 2008;455:697-700.
3. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 2008;455:1054-1056.
4. Coy SL, Cheema AK, Tyburski JB, Laiakis EC, Collins SP, Fornace A, Jr. Radiation metabolomics and its potential in biodosimetry. Int J Radiat Biol 2011;87:802-823.
5. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 2011;8:184-187.
6. Hartman AL, Lough DM, Barupal DK, et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci USA 2009;106:17187-17192.
7. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996;110:1820-1834. (Pubitemid 26169220)
8. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: Results of the pathology workshop at the VIII International small bowel transplant symposium. Transplant Proc 2004;36:335-337. (Pubitemid 38407186)
9. Sheikh KD, Khanna S, Byers SW, Fornace A, Jr., Cheema AK. Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolome. J Biomol Tech 2011;22:1-4.
10. Kaur P, Sheikh K, Kirilyuk A, et al. Metabolomic profiling for biomarker discovery in pancreatic cancer. Int J Mass Spec 2012;310:44-51.
11. Breiman L. Random Forests. Machine Learning 2001;45:5-32. (Pubitemid 32933532)
12. Cui Q, Lewis IA, Hegeman AD, et al. Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol 2008;26:162-164. (Pubitemid 351225941)
13. Wishart DS, Tzur D, Knox C, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007;35(Database issue):D521-D526. (Pubitemid 46056263)
14. Naesens M, Sarwal MM. Molecular diagnostics in transplantation. Nat Rev Nephrol 2010;6:614-628.
15. Wishart DS. Metabolomics: The principles and potential applications to transplantation. Am J Transplant 2005;5:2814-20. (Pubitemid 43923941)
16. Wang JN, Zhou Y, Zhu TY, Wang X, Guo YL. Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS. J Proteome Res 2008;7:3597-3601.
17. Serkova NJ, Zhang Y, Coatney JL, et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation 2007;83:517-521. (Pubitemid 46667858)
18. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 2005;67:1142-1151. (Pubitemid 41623341)
19. Christians U, Schmitz V, Schoning W, Bendrick-Peart J, Klawitter J, Haschke M. Toxicodynamic therapeutic drug monitoring of immunosuppressants: Promises, reality, and challenges. Ther Drug Monit 2008;30:151-158. (Pubitemid 351521641)
20. Foxall PJ, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993;43:234-245. (Pubitemid 23167471)
21. Rush D, Somorjai R, Deslauriers R, Shaw A, Jeffery J, Nickerson P. Subclinical rejection-a potential surrogate marker for chronic rejection-may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 2000;5:44-49.
22. Bell JD, Lee JA, Lee HA, Sadler PJ, Wilkie DR, Woodham RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta 1991;1096:101-107.
23. Legido-Quigley C, McDermott L, Vilca-Melendez H, Murphy GM, Heaton N, Lindon JC, et al. Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation. Electrophoresis 2011;32:2063-2070.
24. Urayama S, Zou W, Brooks K, Tolstikov V. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom 2010;24:613-620.
25. Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed 2009;22:342-348.
26. Gao X, Pujos-Guillot E, Martin JF, et al. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 2009;393:163-175.
27. Shiomi Y, Nishiumi S, Ooi M, et al. GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis 2011;17:2261-2274.
28. Lin HM, Helsby NA, Rowan DD, Ferguson LR. Using metabolomic analysis to understand inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:1021-1029.
29. Marchesi JR, Holmes E, Khan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007;6:546-551. (Pubitemid 46340158)
30. Jansson J, Willing B, Lucio M, et al. Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One 2009;4:e6386.
31. Hammarstrom S. Leukotrienes. Annu Rev Biochem 1983;52:355-377. (Pubitemid 13030687)
32. Shibata A, Katsunuma T, Tomikawa M, et al. Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma. Chest 2006;130:1718-1722. (Pubitemid 46033424)
33. Saibeni S, Cattaneo M, Vecchi M, et al. Low vitamin B (6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: Role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 2003;98:112-117. (Pubitemid 36135178)
34. Johnson CH, Gonzales FJ. Challenges and opportunities of metabolomics. J Cell Physiol 2012;227:2975-2981.
35. Sarwal MM. Deconvoluting the 'omics' for organ transplantation. Curr Opin Organ Transplant 2009;14:544-551.
36. Kumar AR, Li X, Leblanc JF, et al. Proteomic analysis reveals innate immune activity in intestinal transplant dysfunction. Transplantation 2011;92:112-119.
37. Oh PL, Martinez I, Sun Y, Walter J, Peterson DA, Mercer DF. Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants. Am J Transplant 2012;12:753-762.